Reviewed by:
Prescription required
Zafirlukast is a prescription medication used for the long-term management of asthma. It belongs to a class of drugs called leukotriene receptor antagonists (LTRAs). These medications help reduce airway inflammation and prevent asthma symptoms.
Zafirlukast is not a rescue inhaler and does not provide immediate relief during an asthma attack. Instead, it is taken daily to help prevent symptoms such as wheezing, shortness of breath, chest tightness, and coughing. Although the brand name Accolate® has been discontinued in the United States, generic zafirlukast remains available.
Ready to Fill
Zafirlukast
Accolate (brand discontinued; generic available)
Leukotriene Receptor Antagonist
Not a controlled medication
Oral tablet
20 mg twice daily (adults and children over 12 years)
Basics
Zafirlukast is a leukotriene receptor antagonist (LTRA). Primarily used to manage and treat asthma, Zafirlukast helps alleviate symptoms by reducing airway inflammation. Its action is crucial for patients with chronic asthma, as it helps prevent asthma attacks and improve overall respiratory function. Zafirlukast stands as a generic alternative to the branded drug Accolate, offering an economical option for individuals requiring long-term asthma management.
In the landscape of asthma treatments, Zafirlukast distinguishes itself by its unique mechanism: it directly interacts with leukotriene receptors, which are part of the inflammatory cascade in asthma. This impact not only helps reduce asthma symptoms but also helps keep the airways clear by mitigating factors such as bronchoconstriction and excess mucus production. As a result, Zafirlukast plays a vital role in the comprehensive treatment plan for asthma by maintaining steady airway function and enhancing the quality of life for those who suffer from this condition.
Note: This medication’s generic and brand-name formulations are used interchangeably throughout this article.
Accolate was the original brand-name version of zafirlukast. It was approved by the U.S. Food and Drug Administration (FDA) in 1996 for the chronic treatment of asthma. While the brand-name product Accolate® has been discontinued in the United States, generic zafirlukast remains available and provides the same active ingredient and therapeutic effect. Patients prescribed Accolate today typically receive the generic form, zafirlukast, unless their healthcare provider specifies otherwise.
Indications
Zafirlukast has specific applications in the treatment and management of asthma and other airway conditions. It serves both as a preventive treatment and as a supportive medication for ongoing asthma management.
While primarily known for its role in asthma management, Zafirlukast also finds application in treating other conditions due to its anti-inflammatory properties.
The versatility of Zafirlukast in addressing these conditions highlights its importance in respiratory care. By functioning as a preventive agent, it reduces the need for rescue treatments and supports better management of chronic inflammatory respiratory disorders. Its role in the therapeutic landscape provides patients with more options to tailor their asthma management to better suit their individual needs.
Mechanism
Zafirlukast plays a crucial role in asthma management by targeting the inflammatory pathway associated with leukotrienes. Understanding its mechanism of action and pharmacokinetics provides insight into how it effectively manages respiratory conditions.
Zafirlukast binds to and blocks leukotriene receptors in the airway walls. Leukotrienes are potent chemicals produced during inflammatory responses that contribute to airway constriction, heightened mucus production, and overall inflammation. By inhibiting the interaction between leukotrienes and their receptors, Zafirlukast reduces bronchoconstriction and mucus production.
This allows the bronchial muscles to relax, improving airway opening and overall breathing function. The blocking of these receptors is pivotal in controlling the chronic inflammatory process that characterizes asthma.
Upon oral administration, Zafirlukast is well absorbed, reaching peak plasma concentrations within 1 to 3 hours. Its bioavailability is susceptible to interference from food, which can reduce absorption, underscoring the importance of taking the medication on an empty stomach for optimal efficacy.
Following absorption, Zafirlukast is extensively metabolized in the liver. It is predominantly excreted through feces, with a half-life of approximately 10 hours, making it sufficiently long-acting to support twice-daily dosing regimens. The pharmacokinetic profile of Zafirlukast supports its application as a reliable long-term treatment option in chronic asthma care.
Through its mechanism of action and pharmacokinetic properties, Zafirlukast offers sustained relief for asthma sufferers, and patients are advised to adhere to prescribed dosing schedules to maintain consistent therapeutic levels in the body. This therapeutic consistency facilitates better asthma control, reducing both the frequency and severity of asthma symptoms and attacks.
Dosage
Understanding the correct dosages and administration guidelines for Zafirlukast is crucial for its effectiveness in managing asthma. Proper use ensures that the medication can efficiently reduce inflammation and prevent asthma symptoms.
The prescribed dosage must be strictly followed to ensure optimal control of asthma symptoms. Adjustments should only be made under professional medical guidance.
Zafirlukast should be taken on an empty stomach to optimize its absorption. Specifically, it should be consumed either 1 hour before meals or 2 hours after meals. Maintaining consistent dosing intervals enhances the drug’s efficacy by maintaining stable blood levels. The medication is available as an oral tablet, and adherence to a regular dosing schedule is encouraged to achieve the best outcomes in terms of symptom control and reduction of asthma attacks.
If a dose is missed, it should be taken as soon as remembered. However, if it’s nearly time for the next scheduled dose, skip the missed dose to avoid doubling up. Regular adherence to the dosing schedule is key to maintaining therapeutic effectiveness.
In the event of an overdose, immediate medical attention is required. Symptoms such as headache, drowsiness, or gastrointestinal discomfort may occur, necessitating prompt evaluation by healthcare professionals to manage any adverse effects and prevent complications.
By following these guidelines, patients can ensure they use Zafirlukast effectively for asthma management. Consistency and adherence to prescribed dosing regimens play a crucial role in the successful control of asthma symptoms and overall management of the condition.
Why pay retail prices for the same medication?
At Invictus, we source directly from trusted, FDA-approved manufacturers to keep your costs low without sacrificing quality. Whether you need a one-time fill or regular refills, our transparent pricing makes it easy to save every day.
Side Effects
While Zafirlukast is generally well-tolerated, as with any medication, it may cause side effects. These can range from common and mild to serious and warrant attention from healthcare providers.
These common side effects are typically mild and often diminish as treatment continues. However, if they persist or cause significant discomfort, consulting with a healthcare provider is advisable.
Pregnant women should use Zafirlukast only if the benefits justify the potential risks. Consulting a healthcare provider is essential before starting the medication during pregnancy. The occurrence of any serious side effects necessitates stopping the medication and seeking medical attention promptly, as early intervention can prevent further complications. Understanding potential risks helps patients use Zafirlukast safely and effectively as part of their asthma management plan.
Interactions
Zafirlukast can interact with other medications, affecting its efficacy and safety. Awareness of these interactions is key to optimizing treatment and preventing adverse effects.
Being vigilant about potential drug interactions ensures the safe and effective use of Zafirlukast. Patients should always inform their physicians of all the medications they take, including over-the-counter drugs and supplements, to manage potential interactions.
Awareness and management of these interactions contribute to a safer and more effective asthma treatment plan. Engaging with healthcare providers to tailor therapy and monitor potential interactions can optimize Zafirlukast use while minimizing associated risks.
Contraindications
Zafirlukast is generally well-tolerated; however, certain conditions warrant caution or avoidance of this medication. Recognizing these contraindications ensures patients receive the safest and most effective treatment.
Understanding absolute contraindications helps healthcare providers identify patients who may need alternative therapies. These should be closely evaluated for other asthma treatments that don’t carry the same risks.
Recognizing these contraindications and precautions ensures that Zafirlukast is used safely and effectively, minimizing potential risks while maximizing therapeutic benefits in asthma management. Working closely with healthcare providers to monitor health changes and adjust treatment as necessary is essential. This proactive approach to managing asthma with Zafirlukast enhances patient safety and treatment effectiveness.
The information provided on this page is for general informational purposes only and is not intended as medical advice. Always consult with a licensed healthcare provider before starting, stopping, or changing any medication regimen. While Invictus strives to provide accurate and up-to-date information, individual health conditions and circumstances vary. The prices, availability, and descriptions of all medications on this page are subject to change.
Your Prescription
Ready to Fill
Need Help?